Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

1st Immunotherapy of Cancer Conference (ITOC 1)

12 - 14 Mar 2014
TBA, Munich, Germany
Emerging pathways in immunotherapy
Prof Christopher Höller - Medical University of Vienna, Vienna, Austria
Emerging pathways in immunotherapy ( Prof Christopher Höller - Medical University of Vienna, Vienna, Austria )
20 May 2014
Checkpoint blockade: a concept or already a reality?
Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale', Naples...
Checkpoint blockade: a concept or already a reality? ( Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale', Naples, Italy )
20 May 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014
Biomarker development for ipilimumab and prostate GVAX treatment
Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlan...
Biomarker development for ipilimumab and prostate GVAX treatment ( Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands )
26 Mar 2014
Toll like receptor 7 agonists for cancer immunotherapy
Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany
Toll like receptor 7 agonists for cancer immunotherapy ( Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany )
25 Mar 2014
Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MG...
Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg,...
Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703 ( Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg, Germany )
25 Mar 2014
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocyte...
Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denm...
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated fr...
Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014
Molecular pathways associated with immune modulation and thalidomide analogues
Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, C...
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014
Dendritic cell vaccination combined with CTLA4 blockade
Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium
Dendritic cell vaccination combined with CTLA4 blockade ( Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium )
25 Mar 2014
mRNA-based cancer vaccines
Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh
mRNA-based cancer vaccines ( Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh )
24 Mar 2014
Immuno-biological properties of human cancer stem cells
Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena,...
Immuno-biological properties of human cancer stem cells ( Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy )
24 Mar 2014
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma...
Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer ( Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland )
24 Mar 2014